Joshua Biddle, MD
Hospice/Palliative Care · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 16
- 2 carriers
- Office
- 1
Offices
1 location · Regents Univ of California UCSF · 276 clinicians in this group
Hospitals listed: 051508 · Marinhealth Medical Center. That is not proof they admit you there this week.
Plans that list them
16 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Biddle’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
16 of 16 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A147017 · Current
Licensed to practise in California · since 2017 · expires 2027-01-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$139,671
Medicare paid this office $139,671 for 306 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 199 | $68,688 | $155 |
| New patient visit (60+ min) | 142 | $26,899 | $189 |
| Advance care planning, first 30 minutes | 195 | $21,508 | $71 |
| Telephone medical discussion with physician, 21-30 minutes | 65 | $11,249 | $106 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 151 | $4,647 | $14 |
See all 6 services
| Long return visit (40+ min) | 199 | $68,688 | $155 |
| New patient visit (60+ min) | 142 | $26,899 | $189 |
| Advance care planning, first 30 minutes | 195 | $21,508 | $71 |
| Telephone medical discussion with physician, 21-30 minutes | 65 | $11,249 | $106 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 151 | $4,647 | $14 |
| Telephone medical discussion with physician, 11-20 minutes | 24 | $2,240 | $83 |
Who their Medicare patients are
306 Original Medicare patients in 2024. Average age 81 · Under 65 4% · 85 and older 39% · Women 49% · Also on Medicaid 19% · Health risk score 2.46. At or below the middle of the specialty; the typical hospice and palliative care clinician is at 2.98.
Conditions among them: High blood pressure 75% · Cancer 40% · Chronic kidney disease 39% · Depression 39% · Coronary heart disease 36% · Atrial fibrillation 31% · Heart failure 30% · Dementia 28% · Diabetes 25% · COPD 19% · Stroke 19%.
The office billed $683,831, Medicare allowed $182,661 and paid $139,671; for 1,398 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 306 | 1,398 | 81 | 2.46 | $683,831 | $139,671 |
| 2023 | 204 | 798 | 80 | 2.40 | $501,582 | $100,600 |
| 2022 | 223 | 807 | 80 | 2.49 | $526,341 | $112,198 |
| 2021 | 184 | 754 | 80 | 2.53 | $507,366 | $98,493 |
| 2020 | 72 | 159 | 79 | 3.04 | $112,334 | $18,267 |
| 2019 | 17 | 32 | 75 | 2.18 | $23,359 | $3,807 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Long return visit (40+ min) | 139 | $51,942 | $153 |
| New patient visit (60+ min) | 101 | $17,835 | $177 |
| Advance care planning, first 30 minutes | 137 | $14,601 | $72 |
| Telephone medical discussion with physician, 21-30 minutes | 60 | $11,379 | $112 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $1,308 | $77 |
2022: 8 services
| Long return visit (40+ min) | 130 | $56,996 | $171 |
| New patient visit (60+ min) | 136 | $29,387 | $216 |
| Advance care planning, first 30 minutes | 154 | $14,161 | $73 |
| Telephone medical discussion with physician, 21-30 minutes | 28 | $6,640 | $128 |
| Short return visit (20+ min) | 16 | $1,340 | $67 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $1,076 | $83 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 34 | $928 | $27 |
| Return visit (30+ min) | 13 | $919 | $66 |
2021: 8 services
| Long return visit (40+ min) | 113 | $51,172 | $155 |
| New patient visit (60+ min) | 129 | $24,650 | $191 |
| Advance care planning, first 30 minutes | 136 | $13,947 | $74 |
| Return visit (30+ min) | 16 | $2,541 | $116 |
| Telephone medical discussion with physician, 11-20 minutes | 18 | $1,883 | $82 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,503 | $116 |
| Short return visit (20+ min) | 14 | $1,307 | $82 |
| Telephone medical discussion with physician, 5-10 minutes | 11 | $921 | $51 |
2020: 4 services
| Long return visit (40+ min) | 38 | $6,754 | $127 |
| New patient visit (60+ min) | 26 | $4,236 | $163 |
| Advance care planning, first 30 minutes | 35 | $2,980 | $71 |
| Return visit (30+ min) | 12 | $1,454 | $97 |
Medicaid work
$1,054 in 2024
Medicaid paid $1,054 for 13 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 13 | $1,054 |
| 2024 | 13 | 1 | 12 | $1,054 |
Drugs they prescribed that Part D paid
$56,346
Pharmacies billed $56,346 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 39% of their Part D prescriptions (268 of 697) in 2024. At or below the middle of the specialty; the typical hospice and palliative care clinician is at 43%. Long-acting opioids: 59% of their opioid prescriptions.
635 generic and fewer than 11 brand-name prescriptions · $56,346 in drug cost · 44 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Buprenorphine | 67 | $14,000 | $209 |
| Movantik | 12 | $7,503 | $625 |
| Fentanyl | 31 | $3,247 | $105 |
| Buprenorphine-Naloxone | 19 | $3,170 | $167 |
| Hydrocodone-Acetaminophen | 34 | $1,233 | $36 |
See all 18 drugs
| Buprenorphine | 67 | $14,000 | $209 |
| Movantik | 12 | $7,503 | $625 |
| Fentanyl | 31 | $3,247 | $105 |
| Buprenorphine-Naloxone | 19 | $3,170 | $167 |
| Hydrocodone-Acetaminophen | 34 | $1,233 | $36 |
| Duloxetine | 49 | $847 | $17 |
| Methadone | 35 | $828 | $24 |
| Oxycodone | 39 | $786 | $20 |
| Buprenorphine | 28 | $697 | $25 |
| Olanzapine | 24 | $661 | $28 |
| Quetiapine | 18 | $440 | $24 |
| Hydromorphone | 16 | $372 | $23 |
| Lactulose | 14 | $352 | $25 |
| Gabapentin | 18 | $284 | $16 |
| Prochlorperazine Maleate | 13 | $257 | $20 |
| Lorazepam | 43 | $251 | $6 |
| Venlafaxine Hcl Er | 19 | $212 | $11 |
| Morphine Sulfate | 11 | $203 | $18 |
Year by year
| 2024 | 697 | 133 | 39% (268) | None | $56,346 |
| 2023 | 549 | 102 | 41% (226) | 7% | $43,965 |
| 2022 | 595 | 93 | 45% (266) | 8% | $45,553 |
| 2021 | 524 | 108 | 50% (264) | 12% | $32,036 |
| 2020 | 84 | 23 | 38% (32) | 19% | $3,515 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Buprenorphine | 45 | $13,677 | $304 |
| Xtampza Er | 11 | $11,632 | $1,057 |
| Buprenorphine-Naloxone | 17 | $2,973 | $175 |
| Duloxetine | 34 | $1,646 | $48 |
| Fentanyl | 22 | $1,385 | $63 |
| Methadone | 52 | $1,057 | $20 |
| Oxycodone | 44 | $1,032 | $23 |
| Hydrocodone-Acetaminophen | 16 | $803 | $50 |
| Topiramate | 13 | $709 | $55 |
| Buprenorphine | 19 | $621 | $33 |
| Lactulose | 16 | $448 | $28 |
| Gabapentin | 28 | $381 | $14 |
| Methylphenidate | 11 | $252 | $23 |
| Venlafaxine Hcl Er | 22 | $216 | $10 |
| Lorazepam | 27 | $133 | $5 |
| Hydromorphone | 14 | $113 | $8 |
2022: 17 drugs
| Buprenorphine | 28 | $9,688 | $346 |
| Methadone | 78 | $2,197 | $28 |
| Hydrocodone-Acetaminophen | 34 | $1,959 | $58 |
| Oxycodone | 53 | $1,552 | $29 |
| Fentanyl | 13 | $1,395 | $107 |
| Lactulose | 20 | $1,071 | $54 |
| Morphine Sulfate | 18 | $847 | $47 |
| Venlafaxine Hcl Er | 42 | $820 | $20 |
| Buprenorphine | 14 | $691 | $49 |
| Ondansetron | 23 | $651 | $28 |
| Methylphenidate | 27 | $628 | $23 |
| Prochlorperazine Maleate | 19 | $603 | $32 |
| Mirtazapine | 14 | $435 | $31 |
| Morphine Sulfate Er | 13 | $371 | $29 |
| Lorazepam | 28 | $280 | $10 |
| Gabapentin | 22 | $232 | $11 |
| Duloxetine | 24 | $228 | $10 |
2021: 15 drugs
| Buprenorphine | 31 | $8,844 | $285 |
| Methadone | 80 | $1,963 | $25 |
| Venlafaxine Hcl Er | 83 | $1,812 | $22 |
| Oxycodone | 68 | $1,511 | $22 |
| Hydrocodone-Acetaminophen | 27 | $819 | $30 |
| Prochlorperazine Maleate | 16 | $581 | $36 |
| Morphine Sulfate Er | 18 | $566 | $31 |
| Lactulose | 23 | $503 | $22 |
| Hydromorphone | 11 | $422 | $38 |
| Mirtazapine | 12 | $379 | $32 |
| Morphine Sulfate | 14 | $379 | $27 |
| Gabapentin | 15 | $298 | $20 |
| Methylphenidate | 13 | $287 | $22 |
| Duloxetine | 13 | $211 | $16 |
| Lorazepam | 11 | $145 | $13 |
2020: 2 drugs
| Oxycodone | 12 | $440 | $37 |
| Venlafaxine Hcl Er | 16 | $287 | $18 |
Professional record
- NPI
- 1386023877
- Licence
- CA A147017California A147017: Current · expires 2027-01-31
- Trained
- University of California, San Francisco School of Medicine, 2015
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RH0002X (207RH0002X)
- Mailing address
- 38 Mountain View Ave, San Rafael, CA, 94901
- NPI first listed
- 2015-05-29
- NPI last updated
- 2021-05-14
- NPI record certified
- 2021-05-14
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305